REQUEST A DEMO
Total
USD $0.00
Search more companies

Medicalsystem Biotechnology Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Analytical Laboratory Instrument Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Medicalsystem Biotechnology Co., Ltd Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Medicalsystem Biotechnology Co., Ltd is a professional integrated company in the field of in vitro diagnostics, specializing in the research, production, and sales of collective external diagnostic products. The company also provides third-party medical diagnostic services. By offering in vitro biochemical diagnostic reagents, in vitro biochemical diagnostic instruments, and third-party medical diagnostic services to medical and health institutions at all levels, the company aims to create a business model that integrates "diagnostic products as the core" and "integration of diagnostic products and diagnostic services," fully meeting the diagnostic needs of medical and health institutions at all levels. The company has been recognized as a high-tech enterprise in Ningbo by the Ningbo Science and Technology Bureau, Ningbo Finance Bureau, Ningbo National Taxation Bureau, and Ningbo Local Taxation Bureau. It has also been identified as a key high-tech enterprise in the Torch Program by the Torch High Technology Industry Development Center of the Ministry of Science and Technology. The company has been awarded the titles of "Innovative Enterprise of Ningbo" and "Leading Enterprise in the Industrial Sector of Ningbo." Its research and development center has been recognized as an enterprise engineering (technology) center in Ningbo and has obtained a certificate as a provincial-level high-tech enterprise research and development center. The company has established an academician workstation in Ningbo and has been approved by the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee to establish a postdoctoral research workstation. The company's main business income, net profit, and market share have shown rapid growth, making it one of the most promising companies in the industry.

Headquarters
299 Qiming South Rd. Yinzhou District Ningbo Zhejiang
Ningbo; Zhejiang; Postal Code: 315104

Contact Details: Purchase the Medicalsystem Biotechnology Co., Ltd report to view the information.

Website: http://www.nbmksw.com

Basic Information
Total Employees:
Purchase the Medicalsystem Biotechnology Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Medicalsystem Biotechnology Co., Ltd report to view the information.
Registered Capital:
Purchase the Medicalsystem Biotechnology Co., Ltd report to view the information.
Financial Auditors:
Purchase the Medicalsystem Biotechnology Co., Ltd report to view the information.
Incorporation Date:
July 22, 2003
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
28.43%
Purchase this report to view the information.
10.44%
Purchase this report to view the information.
5%
Purchase this report to view the information.
3.11%
Purchase this report to view the information.
0.43%
Subsidiaries
Fuzhou Meikangshengde Medical Laboratory Co., Ltd.
100%
Hangzhou Insimcom Health Technology Co., Ltd.
100%
Hangzhou Meikang Shengde Medical Laboratory Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Medicalsystem Biotechnology Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.91%
Total operating revenue
-0.95%
Operating profit (EBIT)
11.51%
EBITDA
-0.17%
Net Profit (Loss) for the Period
12.06%
Total assets
-0.95%
Total equity
8.39%
Operating Profit Margin (ROS)
2.12%
Net Profit Margin
2.02%
Return on Equity (ROE)
0.09%
Debt to Equity Ratio
-4.84%
Quick Ratio
0.56%
Cash Ratio
0.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?